CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The DREAMS project aims to develop treatments for multiple rare neuromuscular disorders by identifying shared biomarkers and conducting high-throughput drug screenings. Utilizing artificial intelligence, it seeks to discover drug targets and candidates, ultimately preparing for adaptive clinical trials to enhance drug…
According to World Health Organization, to date, fewer than 6% of rare diseases (RDs) have an approved treatment option.
In the light of this observation, it appears crucial to develop disruptive approaches that allow to find treatments for multiple RDs.
To achieve this goal, DREAMS will start from 5 rare neuromuscular disorders (NMD) that share common pathophysiological characteristics related to dysfunctions of autophagy and desmin disorganization.
Using skeletal muscle cells derived from indu…
CENTRE D'ETUDE DES CELLULES SOUCHES
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Belgium, Bruxelles / Brussel
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Portugal, Coimbra
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
France, Paris
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
